A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.

Michal HaranVita MirkinAndrei BraesterNurith HarpazOlga ShevetzMarina ShtreiterShulamit GreenbergOrly MordichOrna AmramInbal Binsky-EhrenreichAyelet MaromIdit ShacharYair HerishanuRosa RuchlemerAlain BerrebiLiora ValinskyMordechai ShtalridLev Shvidel

Published in: British journal of haematology (2017)

Keyphrases

monoclonal antibody
clinical trial
case report
phase ii
double blind
nk cells
phase iii
drug induced
placebo controlled